首页 | 本学科首页   官方微博 | 高级检索  
     

艾迪联合白介素-2治疗恶性胸腔积液疗效分析
引用本文:田晓云,吴晓阜. 艾迪联合白介素-2治疗恶性胸腔积液疗效分析[J]. 药物流行病学杂志, 2010, 0(2): 70-71,78
作者姓名:田晓云  吴晓阜
作者单位:枣庄矿业集团中心医院药剂科;枣庄矿业集团中心医院肿瘤科;
摘    要:目的:探讨艾迪注射液在恶性胸腔积液中的疗效。方法:对42例(治疗组)恶性胸腔积液的病例采用先灌注重组人白细胞介素-2100万Iu后胸腔灌注艾迪注射液100ml+0.9%氯化钠注射液60ml,每周1次,连用3~4周,并与38例(对照组)胸腔灌注白细跑介素一2200万U+0.9%氯化钠注射液60ml,每周1次,连用3~4周者进行对比分析。结果:治疗组有效率83.3%,明显高于对照组有效率63.2%(P〈0.05);KPS评分显效率、有效率分别为23.8%和40.5%,10.5%和21.0%,治疗组明显高于对照组(P〈0.05)。治疗组不良反应发生率明显低于对照组。结论:艾迪联合重组人白细胞介素-2对治疗胸腔积液有良好的价值,值得推广应用。

关 键 词:艾迪注射液  白细胞介素-2  胸腔积液  恶性  疗效分析

Clinical Effect of Aidi Injection and Recombitnant Human Interleukin-2 on the Treatment of Malignant Pleural Effusions
Tian Xiaoyun,Wu Xiaofu Central Hospital of Zaozhuang Mining Group,Zaozhuang,Sh,ong,China. Clinical Effect of Aidi Injection and Recombitnant Human Interleukin-2 on the Treatment of Malignant Pleural Effusions[J]. Chinese Journal of Pharmacoepidemiology, 2010, 0(2): 70-71,78
Authors:Tian Xiaoyun  Wu Xiaofu Central Hospital of Zaozhuang Mining Group  Zaozhuang  Sh  ong  China
Affiliation:Tian Xiaoyun,Wu Xiaofu Central Hospital of Zaozhuang Mining Group,Zaozhuang 277011,Sh,ong,China
Abstract:Objective:To investigate the effect of the aidi injection on the treatment of malignant pleural effusion. Method:80 cases with malignant pleural effusion were divided into two groups.The controlled group used the recombinant human interleukin-2(IL-2) injection,2 million IU + NS 60ml(38 cases) and the treatment group used the recombinant human IL-2 injection,1 million IU + NS 60ml and aidi injection 100ml(42 cases) with the perfusion into the pleural cavity once a week respectively for 3-4 weeks.Result:The e...
Keywords:Aidi injection  Recombinant human interleukin-2 injection  Malignant pleural effusions  Central venous catheter  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号